SBTX Stock Price, News & Analysis

SBTX NASDAQ

Company Description

SBTX (NASDAQ: SBTX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

SBTX stock has declined 33.3% over the past year.

This page provides a comprehensive overview of SBTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-33.3%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

SBTX (SBTX) stock. Over the past 12 months, the stock has lost 33.3%.

Latest News

View All

February 23, 2023

—

ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and Real-World Burden of Needle Injectors

February 22, 2023

—

ARS Pharmaceuticals Reacquires European Marketing Rights to neffy® (ARS-1) for the Treatment of Type I Allergic Reactions Including Anaphylaxis

February 9, 2023

—

ARS Pharmaceuticals to Participate in the SVB Securities Virtual Global Biopharma Conference 2023

conferences

November 10, 2022

—

ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis

clinical trial

November 8, 2022

—

ARS Pharmaceuticals Closes Merger with Silverback Therapeutics

acquisition

October 21, 2022

-2.88%

Silverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including Anaphylaxis

fda approval

SBTX has 10 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 5 with negative movement. Key topics include conferences, clinical trial, acquisition, fda approval, earnings. View all SBTX news →

SEC Filings

View All

No SEC filings available for SBTX.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

SBTX Company Profile & Sector Positioning

SBTX (SBTX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.